透過您的圖書館登入
IP:18.217.182.45
  • 期刊

The Association between Hospital Quality of Care and Short-Term Mortality of Acute Myocardial Infarction Patients

醫院照護過程品質與急性心肌梗塞病人死亡之相關性

摘要


目標:評估急性心肌梗塞6項醫院照護過程品質測量與病人出院後30天內死亡情形之相關性。方法:採橫斷性研究,以2007年1月至2009年11月住院主診斷為急性心肌梗塞病人(ICD-9 CM: 410.xx),排除後續治療者(ICD-9 CM: 410.x2),以廣義階層線性模式(HGLM)分析醫院層次的6項照護過程品質測量,對於病人出院後30天內死亡情形之相關性。結果:約85.5%的病人在住院期間曾接受aspirin治療、38.32%曾接受beta-blocker治療、46.75%曾接受ACE inhibitor for LVSD治療、43.91%曾接受低密度膽固醇檢查、41.37%曾接受血管再通術。經病人特質與醫院特質校正後,醫院住院期間beta-blocker使用情形(OR, 0.87; 95% CI, 0.83-0.92)、ACE inhibitor for LVSD使用情形(OR, 0.93; 95% CI, 0.87-0.99)、低密度膽固醇檢查執行情形(OR, 0.87; 95% CI, 0.81-0.93)、血管再通術使用情形(OR, 0.87; 95% CI, 0.81-0.93),以及6項品質測量的綜合分數(OR, 0.84; 95% CI, 0.76-0.92),對於病人出院後30天內死亡風險有顯著影響。結論:醫院照護過程品質測量對於急性心肌梗塞病人出院後30天內死亡風險有顯著影響,且醫院層次照護過程品質測量的應用與改善,將有助於急性心肌梗塞病人照護結果。

並列摘要


Objectives: To evaluate the association of six hospital-level process of care measures and the 30-day mortality. Methods: This is a cross-sectional study. Patients admitted with a principal diagnosis of AMI (ICD-9CM: 410.xx, excluding 410.x2) (n=1,416) between January 2007 and November 2009. Aspirin use during hospitalization, β-blocker use during hospitalization, ACE inhibitor for LVSD use during hospitalization, LDL-c testing, lipid lowering medication, and reperfusion therapy. Outcome included the 30-day mortality of AMI patients. Data were analysed by using a hierarchical generalized linear model (HGLM) to examine whether the 30-day mortality at the patient level varied among different hospital performance adjusted for patient and hospital characteristics. Results: Among those patients, 88.50% received aspirin therapy during hospitalization, 38.32% received β-blocker therapy, 46.75% received ACE inhibitor for LVSD, 43.91% received LDL-C testing, 41.37% received lipid lowering medication, and 40.97% received reperfusion therapy. Overall the 6 quality of care measures were 53.7% of ideal instances. After risk adjustment, β-blocker use during hospitalization (odds ratio [OR], 0.87; 95% confidence interval [CI], 0.83-0.92), ACE inhibitor for LVSD (OR, 0.93; 95% CI, 0.87-0.99), lipid lowering medication (OR, 0.91; 95% CI, 0.86-0.96), reperfusion therapy (OR, 0.87; 95% CI, 0.81-0.93) and composite score of six measures (OR, 0.84; 95% CI, 0.76-0.92) were significantly correlated with 30-day mortality. Conclusions: A significant association between hospital's process performance and patient outcome was found. The outcome of AMI patients could be enhanced by improving process performance.

參考文獻


Gibbons, R.J.,Balady, G.J.,Bricker, J.T.(2002).ACC/AHA guidelines update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines guidelines (committee to update the 1997 exercise testing guidelines).J Am Coll Cardiol.40,1531-40.
Krumholz, H.M.,Anderson, J.L.,Brooks, N.H.(2006).ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on performance measures (writing committee to develop performance measures on ST-elevation and non-STelevation myocardial infarction).J Am Coll Cardiol.47,236-65.
Peterson, E.D.,DeLong, E.R.,Masoudi, F.A.(2010).ACC/AHA 2010 position statement on composite measures for healthcare performance assessment: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures (writing committee to develop a position statement on composite measures).Circulation.121,1780-91.
Department of Health, Executive Yuan, R.O.C. (Taiwan). Statistics of Causes of Death. Taipei: Department of Health, Executive Yuan, R.O.C. (Taiwan)
Antman, E.M.,Anbe, D.T.,Armstrong, P.W.(2004).ACC/AHA guidelines for the management of patients with st-elevation myocardial infarction - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction).J Am Coll Cardiol.44,671-719.

延伸閱讀